Phleboscore in chronic venous disease


  • Siddharth Mulki Department of General Surgery, A. J. Institute of Medical Sciences, Mangalore, Karnataka,
  • Rupa Merlyn Mascarenhas Department of General Surgery, Kasturba Medical College, Mangalore, Karnataka, India
  • Naveen Kumar Salutagi Department of General Surgery, Mahadevappa Rampure Medical College, Kalaburagi, Karnataka, India



CEAP classification, Chronic venous disease, Phleboscore, Venous pathophysiology, Venous hypertension


Background: Chronic venous disease (CVD) is a multifactorial condition affecting among populations worldwide. The symptoms appear early in the progression of the disease and as the time progresses the severity of the disease increases. Thus a proper clinical management tool is essential to prevent potential harms of the disease, which also entails a significant loss of the quality of life in these individuals. The aim of the present study is to make use of the tool phleboscore for the patients with lower limb problems to quantify the risk of developing CVD complications.

Methods: A prospective observational study with 2788 patients with lower limb complaints of venous disease was conducted in the out-patient department at A. J. Institute of medical sciences, Mangalore. Patients were asked about the symptoms of the venous diseases like sensation in the limb, any changes in the limb. The patients with two or more symptoms were assessed with phleboscore questions. Based on the phleboscore a descriptive analysis of the collected data was done.

Results: With regards to the phleboscore patients were divided into three classes; low risk, moderate risk and high risk. Almost 73.6% patients were at medium risk of developing CVD. 7.6% patients at high risk. 63.5% of patients with sedentary lifestyle were at medium risk.

Conclusions: Phleboscore is an essential tool to assess the potential risk of patients developing CVD. This tool helps in early identification of patients who are about to go into high risk group and help them by early interventions to prevent the development of more serious disease.


Nicolaides A.N, Labropoulos N. Burden and suffering in chronic venous disease. Adv Ther. 2019;36(Suppl 1):1-4.

Rabe E, Guex JJ, Pushas A, Scuderi A, Femandez Quesada F; VCP coordinators. Epidemiology of chronic venous disorders in geographically diverse populations: results from the vein consultant programme. Int Angiol. 2012;31(2):105-15.

Ligi D, Croce L, Mannello F. Chronic venous disorders: the dangerous, the good and the diverse. Int J Mol Sci. 2018;19(9):2544.

Heit JA, Rooke TW, Silverstein M, Mohr DN, Lohse CM, Petterson TM, et al. Trends in the incidence of venous stasis syndrome and venous ulcer: a 25 year population based study. J Vasc Surg. 2001;33(5):1022-7.

Porter JM, Moneta GL, Reporting standards in venous disease: An update. J Vasc Surg 1995;21(4):635-45.

Eklop B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004 Dec; 40 (6): 1248-52.

7. Brand FN, Dannenberg AL, Abbott RD, Kannel WB. The epidemiology of varicose veins: the Framingham study. AM J Prev Med. 1988;4(2):96-101.

Kroeger K, Ose C, Rudopsky G, Roesener J, Hirche H, Risk factor of varicose veins. Int Angiol. 2004;23(1):29-34.

Lee AJ, Evas CJ, Allan PL, Ruckley CV, Fowkes FG. Lifestyle factors and the risk of developing Varicose veins: Edinburg vein study. J Clin Epidemol. 2003;56(2):171-9.

Maly S, Julinek D, Klien D. Ten conclusions after 10 years’ experience in radical endovenous laser therapy of lower extremity varicose veins. J Phlebol Lymphol. 2017;10(1):1-4.

Bujan J, Jimeney-Cossio JA, Jurado F, Gimeno MJ, Pascual G, Garcia-Honduvilla N, et al. Evaluation of the smooth muscle cell component and apoptosis in the varicose veins wall. Histol Histopathol. 2000;15(3):745-52.

Labropoulas N. Heamodynamic changes according to the CEAP classification. Phlebolymplogy. 2003;40(40):130-6.

Fowkes FG, Lee AJ, Evans CJ, Allan PL, Bradbury AW, Ruckley CV. Lifestyle risk factors for lower limb venous reflux in the general population: Edinburg Vein study. Int J Epidemoiol. 2001;30(4):846-52.

Widmer LK, DaSilva A, Stahelin H. Peripheral venous disorder prevalence and socio-medical importance. Bern, Switzerland; Hans Huber; 1978.

Evans CJ, Fowkes FG, Ruckley CV, Lee AJ. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburg vein study. J Epidemiol Comm Health. 1999;53(3):149-53.

Jawien A, Grzela T, Ochwat A. Prevalence of chronic venous insufficiency in men and women in Poland: multicentre cross sectional study in 40,095 patients. Phlebol. 2003;18(3):110-22.

Van Rij AM, De Alwis CS, Jiang P, Christie RA, Hill GB, Dutton SJ, et al. Obesity and impaired venous function. Eur J Vasc Endovasc Surg. 2008;35(6):739-44.

Carpentier PH, Maricq HR, Biro C, Poncot-Makinen CO, Franco A. Prevalence, risk factors and clinical patterns of chronic venous disorders of lower limbs, a population based study in France. J Vasc Surg. 2004;40(4):650-9.

Gorski G, Kielar M, Porzycki P, Noszczyk W. Oral contraceptive intake may be inversely correlated with varicose veins and chronic venous insufficiency: analysis of sex related and life style risk factors in women. Phlebologie. 2003;32(4):90-5.

Cornu-Thenard A, Boivin P, Baud JM, De Vincenzi L, Carpentier PH. Importance of the familial factor in varicose veins. Clinical study of 134 families. J Dermatol Surg Oncol. 1994;20(5):318-6.




How to Cite

Mulki, S., Mascarenhas, R. M., & Salutagi, N. K. (2023). Phleboscore in chronic venous disease. International Journal of Research in Medical Sciences, 11(6), 2103–2107.



Original Research Articles